PAFAH1B1 and ovarian cancer: Since PAF-AH 1B2 has been shown to interact with PAF-AH 1B1, Lis1, our results also indicated that even co-overexpression Lis1 with PAF-AH 1B2 WT may be not sufficient to induce the abnormally proliferation in the HOSE, hinting missed a link between over-expression of the PAF-AH 1B2 and ovarian cancer pathogenesis.